Daniel Lynch - Insider Trading & Ownership

Entity: Individual
Summary: The estimated net worth of Daniel Lynch is at least $5.24M dollars as of February 24, 2025. Daniel Lynch is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $5.08M. Daniel Lynch is the Director of 2seventy bio, Inc. and owns shares of 2seventy bio, Inc. (TSVT) stock worth about $145K. Daniel Lynch is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. (BLUE) stock worth about $11.4K.
All Insider Reports: All Insider Reports

Ownership of Daniel Lynch

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SWTX	SpringWorks Therapeutics, Inc.	Director	$5.08M	-$12.4M	-71%	Feb 20, 2025
TSVT	2seventy bio, Inc.	Director	$145K			Jun 13, 2023
BLUE	bluebird bio, Inc.	Director	$11.4K			Nov 11, 2021
XLO	Xilio Therapeutics, Inc.	Director, 10%+ Owner				Oct 21, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.